HEMATOLOGIE
Wetenschappelijke publicaties
12
Aleva* FE, van Mourik* L, Broeders* MEAC, Paling*
AJ, de Jager* CPC. COVID-19 in critically ill patients in North Brabant, the Netherlands: Patient characteristics and outcomes. J Crit Care 2020 August 08;60:111-115. PMID:
32799179.
Brouns, A J W M, Hendriks LEL, van der Noort V, van de Borne, B E E M, Schramel, F M N H, Groen HJM, Biesma*
B, Smit HJM, Dingemans AC. Efficacy of Ibandronate Loading Dose on Rapid Pain Relief in Patients With Non-Small Cell Lung Cancer and Cancer Induced Bone Pain: The NVALT-9 Trial. Front Oncol 2020 June 24;10:890. PMID: 32670872.
de Rouw* N, Boosman RJ, van de Bruinhorst H, Biesma* B, van den Heuvel, M M, Burger DM, Hilbrands LB, Ter Heine R, Derijks* HJ. Cumulative pemetrexed dose increases the risk of nephrotoxicity. Lung Cancer 2020 August 01;146:30-35.
PMID: 32505078.
Jansen SMA, Huis In ‘t Veld, A E, Jacobs W, Grotjohan HP, Waskowsky M, van der Maten J, van der Weerdt A, Hoekstra R, Overbeek MJ, Mollema SA, Tolen, P H C G, Hassan El Bouazzaoui, L H, Vriend JWJ, Roorda JMM, de Nooijer R, van der Lee I, Voogel BAJ, Peels K, Macken*
T, Aerts* JM, Vonk Noordegraaf A, Handoko ML, de Man FS, Bogaard HJ. Noninvasive Prediction of Elevated Wedge Pressure in Pulmonary Hypertension Patients Without Clear Signs of Left-Sided Heart Disease: External Validation of the OPTICS Risk Score. J Am Heart Assoc 2020 August 04;9(15):e015992. PMID: 32750312.
Dammeijer F, De Gooijer CJ, van Gulijk M, Lukkes M, Klaase L, Lievense LA, Waasdorp C, Jebbink M, Bootsma GP, Stigt JA, Biesma* B, Kaijen-Lambers MEH, Mankor J, Vroman H, Cornelissen R, Baas P, Van der Noort V, Burgers JA, Aerts JG.
Immune monitoring in mesothelioma patients identifies novel immune-modulatory functions of gemcitabine associating with clinical response. EBioMedicine 2021 February 01;64:103160. PMID: 33516644.
Hoeijmakers F, Heineman DJ, Daniels JM, Beck N, Tollenaar, R A E M, Wouters, M W J M, Marang-van de Mheen, P J, Schreurs WH, MDT Study Group(Smulders* SA). Variation Between Multidisciplinary Tumor Boards in Clinical Staging and Treatment Recommendations for Patients With Locally Advanced Non-small Cell Lung Cancer. Chest 2020 December 01;158(6):2675-2687. PMID: 32738254.
Klay D, Platenburg, M G J P, van Rijswijk* RHNAJ, Grutters JC, van Moorsel, C H M. ABCA3 mutations in adult pulmonary fibrosis patients: a case series and review of literature.
Curr Opin Pulm Med 2020 May 01;26(3):293-301. PMID:
32238781.
Rojo F, Corassa M, Mavroudis D, Oz AB, Biesma* B, Brcic L, Pauwels P, Sailer V, Gosney J, Miljkovic D, Hader C, Wu M, Almarez T, Penault-Llorca F. International real-world study of DLL3 expression in patients with small cell lung cancer. Lung Cancer 2020 July 27;147:237-243. PMID: 32745892.
van den Broek D, Hiltermann TJN, Biesma* B, Dinjens WNM, ‘t Hart NA, Hinrichs JWJ, Leers MPG, Monkhorst K, van Oosterhout M, Scharnhorst V, Schuuring E, Speel EM, van den Heuvel, M M, van Schaik, R H N, von der Thusen J, Willems SM, de Visser L, Ligtenberg MJL. Implementation of Novel Molecular Biomarkers for Non-small Cell Lung Cancer in the Netherlands: How to Deal With Increasing Complexity.
Front Oncol 2020 January 22;9:1521. PMID: 32039011.
LONGZIEKTEN
Wetenschappelijke publicaties
13
van der Made, C I, Simons A, Schuurs-Hoeijmakers J, van den Heuvel* G, Mantere T, Kersten S, van Deuren RC, Steehouwer M, van Reijmersdal SV, Jaeger M, Hofste T, Astuti G, Corominas Galbany J, van der Schoot V, van der Hoeven H, Hagmolen Of Ten Have, W, Klijn E, van den Meer C, Fiddelaers J, de Mast Q, Bleeker-Rovers CP, Joosten LAB, Yntema HG, Gilissen C, Nelen M, van der Meer, J W M, Brunner HG, Netea MG, van de Veerdonk, F L, Hoischen A. Presence of Genetic Variants Among Young Men With Severe COVID-19. JAMA 2020 July 24. PMID: 32706371.
van Veggel* B, Madeira R Santos, J F V, Hashemi SMS, Paats MS, Monkhorst K, Heideman DAM, Groves M, Radonic T, Smit EF, Schuuring E, van der Wekken, A J, de Langen AJ. Osimertinib treatment for patients with EGFR exon 20 mutation positive non-small cell lung cancer. Lung Cancer 2020 March 01;141:9-13. PMID: 31926441.
Biemans VBC, Sleutjes JAM, de Vries AC, Bodelier AGL, Dijkstra G, Oldenburg B, Lowenberg M, van Bodegraven AA, van der Meulen-de Jong, A E, de Boer, N K H, Srivastava N, West RL, Romkens* TEH, Horjus Talabur Horje, C S, Jansen JM, van der Woude, C J, Hoekstra J, Weersma RK, van Schaik, F D M, Hoentjen F, Pierik MJ, Dutch Initiative on Crohn and Colitis, (ICC). Tofacitinib for ulcerative colitis: results of the prospective Dutch Initiative on Crohn and Colitis (ICC) registry.
Aliment Pharmacol Ther 2020 May 01;51(9):880-888. PMID:
32237087.
de Jong ME, Kanne H, Nissen* LHC, Drenth JPH, Derikx*
LAAP, Hoentjen F. Increased risk of high-grade dysplasia and colorectal cancer in inflammatory bowel disease patients with recurrent low-grade dysplasia. Gastrointest Endosc 2020 June 01;91(6):1334-1342.e1. PMID: 31923409.
de Jong ME, Smits LJT, van Ruijven B, den Broeder N, Russel, M G V M, Romkens* TEH, West RL, Jansen JM, Hoentjen F. Increased Discontinuation Rates of Anti-TNF Therapy in Elderly Inflammatory Bowel Disease Patients.
J Crohns Colitis 2020 July 30;14(7):888-895. PMID:
31974546.
de Jong ME, Taal E, Thomas PWA, Romkens TEH, Jansen*
JM, West RL, Slotman E, Hoentjen F, Russel, M G V M.
Cross-cultural translation and validation of the IBD-control questionnaire in The Netherlands: a patient-reported outcome measure in inflammatory bowel disease. Scand J Gastroenterol 2020 December 10:1-7. PMID: 33300822.
Hallensleben ND, Umans DS, Bouwense SA, Verdonk RC, Romkens* TE, Witteman BJ, Schwartz MP, Spanier MB, Laheij R, van Santvoort HC, Besselink MG, van Hooft JE, Bruno MJ, Dutch Pancreatitis Study Group. The
diagnostic work-up and outcomes of ‘presumed’ idiopathic acute pancreatitis: A post-hoc analysis of a multicentre observational cohort. United European Gastroenterol J 2020 April 01;8(3):340-350. PMID: 32213015.
Heerink* JS, Saat TC, Nissen* LHC, Romkens* TEH, Hoedemakers* RMJ. Fecaal calprotectine in de behandeling van inflammatoir darmlijden. Tijdschrift voor Geneeskunde 2020;76(3):93-98.
Mackay TM, Smits FJ, Latenstein AEJ, Bogte A, Bonsing BA, Bos H, Bosscha* K, Brosens LAA, Hol L, Busch ORC, Creemers GJ, Curvers WL, den Dulk M, van Dieren S, van Driel, L M J W, Festen S, van Geenen, E J M, van der Geest, L G, de Groot, D J A, de Groot, J W B, Haj Mohammad N, Haberkorn BCM, Haver JT, van der Harst E, Hemmink GJM, de Hingh IH, Hoge C, Homs MYV, van Huijgevoort NC, Jacobs, M A J M, Kerver ED, Liem MSL, Los M, Lubbinge H, Luelmo SAC, de Meijer VE, Mekenkamp L, Molenaar IQ, van Oijen, M G H, Patijn GA, Quispel R, van Rijssen LB, Romkens* TEH, van Santvoort HC, Schreinemakers JMJ, Schut* H, Seerden T, Stommel MWJ, Ten Tije AJ, Venneman NG, Verdonk RC, Verheij J, van Vilsteren, F G I, de Vos-Geelen J, Vulink A, Wientjes C, Wit F, Wessels FJ, Zonderhuis B, van Werkhoven CH, van Hooft JE, van Eijck, C H J, Wilmink JW, van Laarhoven, H W M, Besselink MG, Dutch Pancreatic Cancer Group. Impact of nationwide enhanced implementation of best practices in pancreatic cancer care (PACAP-1): a multicenter stepped-wedge cluster randomized controlled trial. Trials 2020 April 16;21(1):334-z. PMID: 32299515.
Nissen* LHC, Stuurman KE, van der Feen* C, Kemperman*
FA, Pruijt* JFM, de Jonge* HJM. Inflammatory bowel disease in Shwachman-Diamond syndrome; is there an association? Clin Res Hepatol Gastroenterol 2020 February 01;44(1):e10-e13. PMID: 31196706.